BIONOTE participates in Gyeonggi Veterinary Conference

Global leader in providing biological raw materials and animal diagnostics company BIONOTE, participated in Gyeonggi Veterinary Conference on the 13th of November in Suwon Convention Center. Gyeonggi Veterinary Conference is an annual conference hosted by the Geyonggi Veterinary Medicine Association where approximately 2,000 veterinarians participate in order to discuss the latest trends and to elevate clinical technology to the next level. Internal medicine, surgery, feline diagnostics are a few of the many different categories of seminars held during the conference and companies that provide medical/diagnostic equipments, medical/diagnostic reagents and distributors participated in the exhibition that is a part of the conference. BIONOTE showcased their latest products such as the Vcheck M, POC PCR analyzer, as well as their Vcheck C, clinical chemistry analyzer, which will be released in the first quarter of 2023, along with their main popular products such as rapid diagnostic kits, Vcheck F and ELISA kits. Furthermore, they gave out free samples of their Vcheck F Feline TnI kit, which can be used to screen for feline heart diseases and screen for feline heart damage, to the visitors of their booth to celebrate the fact that it received the liscence for domestic sales.Through the conference, BIONOTE was able to communicate directly with its customers and receive meaningful feedback, especially regarding the new products, with the great interest shown by the visitors. 

• 2022.11.24
• Hits : 2,840

Bionote Receives Certificate of Free Sales for Feline Rapid Diagnostic Kit... "Immunodeficiency Virus test results in just 15 minutes"

DISCLAIMER: This news article is a direct translation of the original Korean article from MoneyToday. BioNote Inc. does not claim any right to the article or claim any ownership.The translation was completed by BioNote Inc. only for the convenience of non-Korean speaking customers and BioNote Inc. does not seek to redistribute nor acquire profit from the translation. 'FIV Ab/FeLV Ag 2.0' Rapid diagnostic kit that measures the presence of Feline Immunodeficiency Virus and Feline Leukemia Virus is set to enter the 5.3 billion USD worth global pet diagnostic market Bionote announced on the 10th that they have received the Certificate of Free Sales ("CFS") from the Korea Animal and Plant Quarantine Agency for their 'FIV Ab/FeLV Ag 2.0' kit which can test the presence of Feline Immunodeficiency Virus and Feline Leukemia Virus with one kit. Through the CFS, Bionote has acquired the chance to target the global market as well as the domestic market. The pet diagnostic market is estimates to be worth 5.3 billion USD this year. A Bionote spokesperson commented that "The biggest advantage of this new product is that the user is able to screen for the viruses with just a small amount of blood as sample, taking only 15 minutes" and that "By upgrading to version 2.0 from the original kit, we were able to reduce the number of samples required for the test, from two of the same sample to just one sample, making the test process more convenient for the user". Feline Immunodeficiency Virus (FIV) is a retrovirus that destroys a cat's immune system. It affects all animals in the cat family, and it's said around 2.5 - 4.4% of cats worldwide are infected. Routine testing for FIV seems to be needed because, depending on the region, around 1~14% of healthy cats is said to have tested positive for FIV antibodies and around 44% of unhealthy cats is said to have tested positive for FIV antibodies.  Feline Leukemia Virus (FeLV) is a retrovirus that weakens a cat's immune system. FeLV is divided into 4 subgroups; A, B, C, T and it's said to have infected between 2.5 - 7.5 % of cats in North America. Of the two viruses, FIV is typically not fatal to cats, but as time passes, the virus will weaken the immune system of the cat, and this may lead to fatal secondary infection. FeLV is not fatal to cats as well, but it reduces the life expectancy of cats and is easily transmitted between cats, meaning FeLV positive cats must be quarantined with other FeLV positive cats. Link: https://news.mt.co.kr/mtview.php?no=2022111013352912335 

• 2022.11.11
• Hits : 3,751

Bionote "Enters the global market with POCT PCR device M10"

DISCLAIMER: This news article is a direct translation of the original Korean article from eDaily. BioNote Inc. does not claim any right to the article or claim any ownership.The translation was completed by BioNote Inc. only for the convenience of non-Korean speaking customers and BioNote Inc. does not seek to redistribute nor acquire profit from the translation.  [E-Daily Reporter Seok Ji-heon] Bionote, a global leading company in bio content and animal diagnosis, announced on the 2nd that the " state-of-the-art field molecular diagnostic equipment Vcheck M10 (hereinafter, M10)", which was recently introduced in overseas markets. M10 received favorable reviews at the 2022 World Small Animal Veterinary Association (WSAVA). The event was held in Lima, Peru from the 29th to the 31st of last month.  "We once again confirmed the possibility of success in the global market due to the M10 products' innovative technology," a Bionote official said. "Bionote, which has previously shown expertise in immunodiagnosis, will become a global leader in providing total solutions from initial screening to PCR confirmation."M10 is an automated device that integrates nucleic acid extraction and nucleic acid amplification (PCR) into one device, which was previously carried out by separate equipments. M10 has a very simple inspection process, so using this equipment, veterinarians at general veterinary hospitals can conduct PCR tests at animal hospitals without additional training. The company explained that this is groundbreaking because it can quickly and accurately perform PCR confirmation tests at the field in an hour, which was requested by a professional inspection agency, which took about 1 to 3 days.M10 equipment has completed the export license of the quarantine headquarters and the European CE certification, and is preparing for domestic use. As a cartridge used in M10 equipment, "Vcheck MEhrlichia/Anaplasma" was launched overseas for the first time in September this year, and "Vcheck M Babesia gibsoni/canis" was developed as the second item and is being prepared for overseas launch in November. Cartridges that can test up to eight types of animal diseases at a time will also be introduced within this year.Meanwhile, Bionote is seeking to be listed on the KOSPI within this year to accelerate global growth.Link: https://pharm.edaily.co.kr/news/read?newsId=01443206632521784&mediaCodeNo=257 

• 2022.11.03
• Hits : 4,033